Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, et al. Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions. Epilepsia. 2019a;60(11):2224–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anderson LL, Low IK, Banister SD, McGregor IS, Arnold JC. Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome. J Nat Prod. 2019b;82(11):3047–55.
Article
CAS
PubMed
Google Scholar
Bakas T, van Nieuwenhuijzen PS, Devenish SO, McGregor IS, Arnold JC, Chebib M. The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors. Pharmacol Res. 2017;119:358–70.
Article
CAS
PubMed
Google Scholar
Berecki G, Bryson A, Terhag J, Maljevic S, Gazina EV, Hill SL, et al. SCN1A gain of function in early infantile encephalopathy. Ann Neurol. 2019;85(4):514–25.
Article
CAS
PubMed
Google Scholar
Berecki G, Howell KB, Deerasooriya YH, Cilio MR, Oliva MK, Kaplan D, et al. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy. Proc Natl Acad Sci United States America. 2018;115(24):E5516–25.
Article
CAS
Google Scholar
Berkovic SF, Mulley JC, Scheffer IE, Petrou S. Human epilepsies: interaction of genetic and acquired factors. Trends Neurosci. 2006;29(7):391–7.
Article
CAS
PubMed
Google Scholar
Blanchard MG, Willemsen MH, Walker JB, Dib-Hajj SD, Waxman SG, Jongmans MC, et al. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. J Med Genet. 2015;52(5):330–7.
Article
CAS
PubMed
Google Scholar
Brunklaus A, Zuberi SM. Dravet syndrome--from epileptic encephalopathy to channelopathy. Epilepsia. 2014;55(7):979–84.
Article
CAS
PubMed
Google Scholar
Capano A, Weaver R, Burkman E. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgrad Med. 2020;132(1):56–61.
Article
PubMed
Google Scholar
Cheah CS, Westenbroek RE, Roden WH, Kalume F, Oakley JC, Jansen LA, et al. Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. Channels (Austin, Tex.). 2013;7(6):468–72.
Article
CAS
Google Scholar
Chen YJ, Shi YW, Xu HQ, Chen ML, Gao MM, Sun WW, et al. Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. Mol Neurobiol. 2015;51(3):1263–70.
Article
CAS
PubMed
Google Scholar
de Kovel CG, Meisler MH, Brilstra EH, van Berkestijn FM, van’t Slot R, van Lieshout S, et al. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy. Epilepsy Res. 2014;108(9):1511–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet. 2009;46(3):183–91.
Article
CAS
PubMed
Google Scholar
Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet. Neurol. 2016;15(3):270–8.
Article
CAS
PubMed
Google Scholar
Djemie T, Weckhuysen S, von Spiczak S, Carvill GL, Jaehn J, Anttonen AK, et al. Pitfalls in genetic testing: the story of missed SCN1A mutations. Mol Genet Genomic Med. 2016;4(4):457–64.
Article
CAS
PubMed
PubMed Central
Google Scholar
Duan Y, Liao C, Jain S, Nicholson RA. The cannabinoid receptor agonist CP-55,940 and ethyl arachidonate interfere with [(3) H]batrachotoxinin A 20 alpha-benzoate binding to sodium channels and inhibit sodium channel function. Comparative biochemistry and physiology. Toxicol Pharmacol. 2008;148(3):244–9.
Google Scholar
Epi4K. De novo mutations in epileptic encephalopathies. Nature. 2013;501(7466):217–21.
Article
CAS
Google Scholar
Estacion M, O'Brien JE, Conravey A, Hammer MF, Waxman SG, Dib-Hajj SD, et al. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy. Neurobiol Dis. 2014;69:117–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gazina EV, Richards KL, Mokhtar MB, Thomas EA, Reid CA, Petrou S. Differential expression of exon 5 splice variants of sodium channel alpha subunit mRNAs in the developing mouse brain. Neuroscience. 2010;166(1):195–200.
Article
CAS
PubMed
Google Scholar
Ghovanloo MR, Shuart NG, Mezeyova J, Dean RA, Ruben PC, Goodchild SJ. Inhibitory effects of cannabidiol on voltage-dependent sodium currents. J Biol Chem. 2018;293(43):16546–58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gray RA, Stott CG, Jones NA, Di Marzo V, Whalley BJ. Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent. Cannabis Cannabinoid Res. 2020;5(2):145–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gray RA, Whalley BJ. The proposed mechanisms of action of CBD in epilepsy. Epileptic Disord. 2020;22(S1):10–5.
PubMed
Google Scholar
Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, et al. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci Lett. 2008;433(1):65–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu W, Tian C, Li T, Yang M, Hou H, Shu Y. Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation. Nat Neurosci. 2009;12(8):996–1002.
Article
CAS
PubMed
Google Scholar
Huntsman RJ, Tang-Wai R, Alcorn J, Vuong S, Acton B, Corley S, et al. Dosage related efficacy and tolerability of cannabidiol in children with treatment-resistant epileptic encephalopathy: preliminary results of the CARE-E study. Front Neurol. 2019;10:716.
Article
PubMed
PubMed Central
Google Scholar
Kaplan JS, Stella N, Catterall WA, Westenbroek RE. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc Natl Acad Sci U S A. 2017;114(42):11229–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Knapp O, Nevin ST, Yasuda T, Lawrence N, Lewis RJ, Adams DJ. Biophysical properties of Na(v) 1.8/Na(v) 1.2 chimeras and inhibition by microO-conotoxin MrVIB. Bri J Pharmacol. 2012;166(7):2148–60.
Article
CAS
Google Scholar
Lamar T, Vanoye CG, Calhoun J, Wong JC, Dutton SBB, Jorge BS, et al. SCN3A deficiency associated with increased seizure susceptibility. Neurobiol Dis. 2017;102:38–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leal-Cardoso JH, da Silva-Alves KS, Ferreira-da-Silva FW, dos Santos-Nascimento T, Joca HC, de Macedo FH, et al. Linalool blocks excitability in peripheral nerves and voltage-dependent Na+ current in dissociated dorsal root ganglia neurons. Eur J Pharmacol. 2010;645(1-3):86–93.
Article
CAS
PubMed
Google Scholar
Miller LL, Pellock JM, DeLorenzo RJ, Meyer JM, Corey LA. Univariate genetic analyses of epilepsy and seizures in a population-based twin study: the Virginia Twin Registry. Genet Epidemiol. 1998;15(1):33–49.
Article
CAS
PubMed
Google Scholar
Nuutinen T. Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus. Eur J Med Chem. 2018;157:198–228.
Article
CAS
PubMed
Google Scholar
Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci. 2007;27(22):5903–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Okada Y, Imendra KG, Miyazaki T, Hotokezaka H, Fujiyama R, Zeredo JL, et al. Biophysical properties of voltage-gated Na+ channels in frog parathyroid cells and their modulation by cannabinoids. J Exp Biol. 2005;208(Pt 24):4747–56.
Article
CAS
PubMed
Google Scholar
Parrini E, Marini C, Mei D, Galuppi A, Cellini E, Pucatti D, et al. Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Hum Mutat. 2017;38(2):216–25.
Article
CAS
PubMed
Google Scholar
Perucca P, Perucca E. Identifying mutations in epilepsy genes: impact on treatment selection. Epilepsy Res. 2019;152:18–30.
Article
CAS
PubMed
Google Scholar
Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, et al. Cannabidiol: state of the art and new challenges for therapeutic applications. Pharmacol Therapeut. 2017;175:133–50.
Article
CAS
Google Scholar
Richards KL, Milligan CJ, Richardson RJ, Jancovski N, Grunnet M, Jacobson LH, et al. Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death. Proc Natl Acad Sci U S A. 2018;115(34):E8077–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Russo EB. The case for the entourage effect and conventional breeding of clinical cannabis: no “strain,” no gain. Front Plant Sci. 2019;9:1969. https://doi.org/10.3389/fpls.2018.01969. eCollection 2018.
Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Bri J Pharmacol. 2011;163(7):1344–64.
Article
CAS
Google Scholar
Speed D, O'Brien TJ, Palotie A, Shkura K, Marson AG, Balding DJ, et al. Describing the genetic architecture of epilepsy through heritability analysis. Brain. 2014;137:2680–9.
Article
PubMed
PubMed Central
Google Scholar
Stein RE, Kaplan JS, Li J, Catterall WA. Hippocampal deletion of NaV1.1 channels in mice causes thermal seizures and cognitive deficit characteristic of Dravet Syndrome. Proc Natl Acad Sci U S A. 2019;116(33):16571–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sun Y, Dolmetsch RE. Investigating the therapeutic mechanism of cannabidiol in human induced pluripotent stem cell (iPSC)-based model of Dravet syndrome. 2018. https://doi.org/10.1101/sqb.2018.83.038174.
Suraev A, Lintzeris N, Stuart J, Kevin RC, Blackburn R, Richards E, et al. Composition and use of cannabis extracts for childhood epilepsy in the Australian community. Sci Rep. 2018;8(1):10154.
Article
CAS
PubMed
PubMed Central
Google Scholar
Suraev AS, Todd L, Bowen MT, Allsop DJ, McGregor IS, Ireland C, et al. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy Behav. 2017;70(Pt B):334–40.
Article
PubMed
Google Scholar
Turkanis SA, Partlow LM, Karler R. Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cells. Neuropharmacology. 1991;30(1):73–7.
Article
CAS
PubMed
Google Scholar
Vanoye CG, Gurnett CA, Holland KD, George AL Jr, Kearney JA. Novel SCN3A variants associated with focal epilepsy in children. Neurobiol Dis. 2014;62:313–22.
Article
CAS
PubMed
Google Scholar
Veeramah KR, O'Brien JE, Meisler MH, Cheng X, Dib-Hajj SD, Waxman SG, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet. 2012;90(3):502–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Watkins AR. Cannabinoid interactions with ion channels and receptors. Channels (Austin, Tex.). 2019;13(1):162–7.
Article
Google Scholar
Whitaker WR, Faull RL, Waldvogel HJ, Plumpton CJ, Emson PC, Clare JJ. Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res Mol Brain Res. 2001;88(1-2):37–53.
Article
CAS
PubMed
Google Scholar
Zhang HB, Bean BP. Cannabidiol inhibition of murine primary nociceptors: tight binding to slow inactivated states of Nav1.8 channels. J Neurosci. 2021;41(30):6371–87.
Article
CAS
PubMed
PubMed Central
Google Scholar